No Data
No Data
12 Health Care Stocks Moving In Monday's Pre-Market Session
Wedbush Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $42
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating
J.P. Morgan Reaffirms Their Buy Rating on AnaptysBio (ANAB)
AnaptysBio Chief Legal Officer Sells Over $490k in Company Stock
BTIG Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $55
BTIG analyst Jake Fuller initiates coverage on $AnaptysBio(ANAB.US)$ with a buy rating, and sets the target price at $55.According to TipRanks data, the analyst has a success rate of 48.1% and a